biomedcentral.com/content
Bottom,Top,Right1
  • Welcome Stanford University
  • Log on
  • biomed central
  • chemistry central
  • SpringerOpen
BioMed Central
Advanced search
  • Home
  • Journals
  • Articles
  • Gateways
  • About BioMed Central
  • My BioMed Central

Submit a manuscript Register Sign up for article alerts Contact us
Advertisement

Articles

  • All articles RSS
  • Most popular RSS
  • Supplements
  • My latest articles
  • Article collections

HIV thirty years on

Collection published: 21 May 2013

Last updated: 3 September 2013

It has been thirty years since human immunodeficiency virus (HIV) was first identified as the cause of acquired immunodeficiency syndrome (AIDS) , a landmark discovery that has led to tremendous progress in understanding and combating infection by this life-threatening retrovirus. The most notable achievement during this time has been the development of antiretroviral therapies that substantially improve the quality and length of life in infected individuals. Nevertheless, to date neither a complete cure nor a protective vaccine have been found, and new infections continue to occur at a rate of 6850 people per day.

In this cross-journal series, Retrovirology, BMC Medicine and BMC Biology take stock of where we are now, with a collection of articles that discuss different aspects of HIV infection, the progress made towards eradicating the virus, and the challenges of fundamental science and clinical management that remain. Selected research articles will be included in addition to invited reviews and comment.


Review   Open Access Highly Accessed

Modeling the within-host dynamics of HIV infection

Alan S Perelson, Ruy M Ribeiro BMC Biology 2013, 11:96 (3 September 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Alan Perelson and Ruy Ribeiro explain how differential equations that model the dynamics of HIV replication in its human host have led to important quantitative insights into the biology of HIV infection.

Review   Open Access Highly Accessed

Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013

Antoinette C van der Kuyl, Margreet Bakker, Suzanne Jurriaans, Nicole KT Back, Alexander O Pasternak, Marion Cornelissen, Ben Berkhout Retrovirology 2013, 10:93 (28 August 2013)

Abstract | Full text | PDF | ePUB | PubMed

Review   Open Access

Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?

Jean-Michel Molina, Claire Pintado, Caroline Gatey, Diane Ponscarme, Pierre Charbonneau, Benedicte Loze, Willy Rozenbaum, Constance Delaugerre BMC Medicine 2013, 11:186 (23 August 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Pre-exposure prophylaxis (PrEP) with antiretroviral therapy is thought to help prevent HIV transmission; Jean-Michel Molina and colleagues discuss the controversy surrounding PrEP in Europe, and highlight the issues that need to be addressed.

Review   Open Access Highly Accessed

Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention

Ravindra K Gupta, David A M C Van de Vijver, Sheetal Manicklal, Mark A Wainberg Retrovirology 2013, 10:82 (31 July 2013)

Abstract | Full text | PDF | ePUB | PubMed

Review   Open Access Highly Accessed

Development of prophylactic vaccines against HIV-1

Torben Schiffner, Quentin J Sattentau, Lucy Dorrell Retrovirology 2013, 10:72 (17 July 2013)

Abstract | Full text | PDF | PubMed

Question and Answer   Open Access

Video Q&A: Rapid urine LAM test for HIV-associated TB - potential to reduce deaths? An interview with Stephen Lawn

Stephen D Lawn BMC Medicine 2013, 11:158 (4 July 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

In this Q&A, we talk to Stephen Lawn about the point-of-care LAM test for HIV-associated TB, which could save lives by improving rapid diagnosis and treatment.

Review   Open Access Highly Accessed

HIV-1 transcription and latency: an update

Carine Van Lint, Sophie Bouchat, Alessandro Marcello Retrovirology 2013, 10:67 (26 June 2013)

Abstract | Full text | PDF | ePUB | PubMed

Debate   Open Access

When to start antiretroviral therapy: the need for an evidence base during early HIV infection

Jens D Lundgren, Abdel G Babiker, Fred M Gordin, Álvaro H Borges, James D Neaton BMC Medicine 2013, 11:148 (14 June 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Jens Lundgren and colleagues argue for a more cautious approach to starting antiretroviral therapy, highlighting that there is no evidence from randomized trials to suggest the benefits of starting therapy early outweigh the potential harms.

Debate   Open Access

When to start antiretroviral therapy: as soon as possible

Ricardo A Franco, Michael S Saag BMC Medicine 2013, 11:147 (14 June 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Ricardo Franco and Michael Saag discuss the benefits of starting HIV therapy early, arguing that treatment should be given as soon as possible to reduce viral replication, prevent transmission and avoid the problems associated with inflammation.

Review   Open Access Highly Accessed

The frantic play of the concealed HIV envelope cytoplasmic tail

Eveline Santos da Silva, Martin Mulinge, Danielle Perez Bercoff Retrovirology 2013, 10:54 (24 May 2013)

Abstract | Full text | PDF | ePUB | PubMed

Review   Open Access Highly Accessed

The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind’s future?

Natasja G de Groot, Ronald E Bontrop Retrovirology 2013, 10:53 (24 May 2013)

Abstract | Full text | PDF | ePUB | PubMed

Interview   Open Access

In pursuit of an HIV vaccine: an interview with Andrew McMichael

Andrew J McMichael BMC Biology 2013, 11:60 (21 May 2013)

Full text | PDF | PubMed |  Editor’s summary

Can the immune system be induced to protect itself against HIV infection? Andrew McMichael gives his perspective in an interview, explaining the challenges faced in making a vaccine  and why he remains optimistic about the potential of eliciting strong T cell responses for controlling the virus.

Opinion   Open Access Highly Accessed

Thirty years on: HIV receptor gymnastics and the prevention of infection

Robin A Weiss BMC Biology 2013, 11:57 (21 May 2013)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Robin Weiss, in an article to mark the 30th anniversary of the discovery of the human immunodeficiency virus (HIV), reviews the complex interactions of the virus with the specialized surface molecules by which it gains entry into cells, and how this has led to drugs that block it.

Review   Open Access Highly Accessed

Molecular signatures of T-cell inhibition in HIV-1 infection

Marie Larsson, Esaki M Shankar, Karlhans F Che, Alireza Saeidi, Rada Ellegård, Muttiah Barathan, Vijayakumar Velu, Adeeba Kamarulzaman Retrovirology 2013, 10:31 (20 March 2013)

Abstract | Full text | PDF | ePUB | PubMed


  • Terms and Conditions
  • Cookies
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.